OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis
Ke-Bin Huang, Feng-Yang Wang, Yuan Lu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 24
Closed Access | Times Cited: 11

Showing 11 citing articles:

Synthesis and Bio-evaluation of Aminoferrocene-Based Anticancer Prodrugs as Potent Ferroptosis Inducers
Qianer Zhang, Xuejing Fan, Huimei Qian, et al.
Inorganic Chemistry Frontiers (2025)
Closed Access

Rhodium(III) Complex Noncanonically Potentiates Antitumor Immune Responses by Inhibiting Wnt/β-Catenin Signaling
Feng-Yang Wang, Liang-Mei Yang, Xiaolin Xiong, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13778-13787
Closed Access | Times Cited: 3

Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Jinzhe Liang, Fangmian Wei, Hui Chao
Smart Molecules (2024)
Open Access | Times Cited: 2

Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational
Nan Yang, Xiaoyi Guo, Jin Ding, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 6, pp. 792-800
Closed Access | Times Cited: 1

Recent advances of Schiff base metal complexes as potential anticancer agents
Lin Lv, Tianpeng Zheng, Lu Tang, et al.
Coordination Chemistry Reviews (2024) Vol. 525, pp. 216327-216327
Closed Access | Times Cited: 1

Recent Advances of Metal Complexes in the Treatment of Hepatocellular Carcinoma
Zhongren Xu, Yu Liu, Jiaqi Yang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1

Research Progress of Natural Product-Conjugated Platinum and Gold Complexes as Potential Antitumor Agents
Meiyu Wang, Fuwei Li, Zhaoran Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116956-116956
Closed Access

Recent advances in discrete Cu complexes for enhanced chemodynamic therapy
Zhao-Guo Hong, Liangliang Zhang, Hong Liang, et al.
Dalton Transactions (2024) Vol. 53, Iss. 48, pp. 19075-19080
Closed Access

More than just DNA damage: Pt(ΙΙ)-NHC complexes derived from 4,5-diarylimidazoles augment immunogenic cell death
Lu Tang, Xingyu Chang, Jing Shi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117014-117014
Closed Access

Hydrazone copper(II) complexes suppressed lung adenocarcinoma by activating multiple anticancer pathway
Aili Li, Wei‐Ping Pan, ZhenLei Zhang, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107994-107994
Closed Access

Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR
Yawen Wang, Xiaoyan Ma, Xuejie Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117137-117137
Closed Access

Page 1

Scroll to top